Dyne Therapeutics, Inc.·4

Apr 4, 9:06 PM ET

McNeill Jonathan 4

4 · Dyne Therapeutics, Inc. · Filed Apr 4, 2024

Insider Transaction Report

Form 4
Period: 2023-07-11
McNeill Jonathan
See Remarks
Transactions
  • Award

    Stock option (right to buy)

    2023-07-11+35,00035,000 total
    Exercise: $11.79Exp: 2033-07-10Common Stock (35,000 underlying)
Footnotes (2)
  • [F1]This transaction is being reported late due to an inadvertent administrative error.
  • [F2]This option award was granted on July 11, 2023 and vests over four years in equal monthly installments, with the first vesting occurring on August 1, 2023 and the remaining vesting occurring each month subsequent to the first vesting date, subject to continuous service.

Documents

1 file
  • 4
    ownership.xmlPrimary

    4